首页> 外文期刊>The American Journal of the Medical Sciences >Potential Value of Coagulation Parameters for Suggesting Preeclampsia During the Third Trimester of Pregnancy
【24h】

Potential Value of Coagulation Parameters for Suggesting Preeclampsia During the Third Trimester of Pregnancy

机译:妊娠三个三三月三个妊娠期孕产病患者凝血参数的潜在价值

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Background Preeclampsia is a relatively common complication of pregnancy and considered to be associated with different degrees of coagulation dysfunction. This study was developed to evaluate the potential value of coagulation parameters for suggesting preeclampsia during the third trimester of pregnancy. Materials and Methods Data from 188 healthy pregnant women, 125 patients with preeclampsia in the third trimester and 120 age-matched nonpregnant women were analyzed. Prothrombin time, prothrombin activity, activated partial thromboplastin time, fibrinogen (Fg), antithrombin, platelet count, mean platelet volume, platelet distribution width and plateletcrit were tested. Results All parameters, excluding prothrombin time, platelet distribution width and plateletcrit, differed significantly between healthy pregnant women and those with preeclampsia. Platelet count, antithrombin and Fg were significantly lower and mean platelet volume and prothrombin activity were significantly higher in patients with preeclampsia ( P 0.001). Among these parameters, the largest area under the receiver operating characteristic curve for preeclampsia was 0.872 for Fg with an optimal cutoff value of ≤2.87 g/L (sensitivity = 0.68 and specificity = 0.98). For severe preeclampsia, the area under the curve for Fg reached up to 0.922 with the same optimal cutoff value (sensitivity = 0.84, specificity = 0.98, positive predictive value = 0.96 and negative predictive value = 0.93). Conclusions Fg is a biomarker suggestive of preeclampsia in the third trimester of pregnancy, and our data provide a potential cutoff value of Fg ≤ 2.87 g/L for screening preeclampsia, especially severe preeclampsia.
机译:摘要背景preclampsia是妊娠的相对常见的并发症,并且被认为与不同程度的凝血功能障碍有关。开发了该研究以评估妊娠三个三个月妊娠期胰腺量参数的潜在价值。分析了来自188名健康孕妇的材料和方法数据,125例妊娠期前三个月和120岁匹配的非妊娠妇女的125名患者。测试凝血酶原时间,凝血酶原活性,活性部分血栓形成素时间,纤维蛋白原(FG),抗血栓,血小板计数,平均血小板体积,血小板分布宽度和血小板。结果所有参数,不包括凝血酶原时间,血小板分布宽度和血小板,在健康的孕妇和具有预先普拉明血症的人之间有显着不同。血小板计数,抗凝血酶和FG显着较低,平均血小板体积和凝血酶体活性在预液位血管患者(P <0.001)的患者中显着高。在这些参数中,PERPlampsia的接收机操作特性曲线下的最大区域为FG为0.872,具有≤2.87g/ L的最佳截止值(灵敏度= 0.68和特异性= 0.98)。对于严重的先兆子痫,FG曲线下的区域达到高达0.922,具有相同的最佳截止值(灵敏度= 0.84,特异性= 0.98,阳性预测值= 0.96和负预测值= 0.93)。结论FG是妊娠第三个三个月前三个三个月的预口普拉姆斯的生物标志物,我们提供FG≤2.87g/ L的潜在截止值,用于筛查预胰抗,特别是严重的预坦克敏。

著录项

  • 来源
  • 作者

    Ying Chen; Li Lin;

  • 作者单位

    Department of Obstetrics and Gynecology Beijing Friendship Hospital Capital Medical University;

    Department of Obstetrics and Gynecology Beijing Friendship Hospital Capital Medical University;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号